HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is low in North Africa but the number of cases of HIV are increasing rapidly. There is no cure for HIV but drugs manufacturing companies are investing huge money in R&D to develop drugs for HIV.
This report contains market size and forecasts of HIV Diagnosis & Treatment in Global, including the following market information:
- Global HIV Diagnosis & Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global HIV Diagnosis & Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
ELISA Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of HIV Diagnosis & Treatment include Abbott Laboratories, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla, F. Hoffmann-La Roche, Gilead, GlaxoSmithKline and Johnson & Johnson, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the HIV Diagnosis & Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global HIV Diagnosis & Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global HIV Diagnosis & Treatment Market Segment Percentages, by Type, 2021 (%)
- ELISA Test
- Saliva Tests
- Viral Load Test
- Western Blot
- Others
Global HIV Diagnosis & Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global HIV Diagnosis & Treatment Market Segment Percentages, by Application, 2021 (%)
Global HIV Diagnosis & Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global HIV Diagnosis & Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies HIV Diagnosis & Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies HIV Diagnosis & Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Cipla
- F. Hoffmann-La Roche
- Gilead
- GlaxoSmithKline
- Johnson & Johnson
